Re: Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
Anthony
A
Atala
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D007211:Indoles; D011720:Pyrazoles; D011758:Pyrroles; D013449:Sulfonamides; D051546:Cyclooxygenase 2